The DOI matches its Crossref record.
Carvedilol, a new nonselective beta-blocker with intrinsic anti-alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis
Abstract
Only some patients show a substantial hepatic venous pressure gradient (HVPG) reduction after propranolol, which makes it desirable to investigate drugs with greater portal hypotensive effect. The aim of this study was to investigate whether carvedilol, a nonselective beta-blocker with anti-alpha 1-adrenergic activity, may cause a greater HVPG reduction than propranolol. Thirty-five cirrhotic patients had hemodynamic measurements before and after the random administration of carvedilol (n = 14), propranolol (n = 14), or placebo (n = 7). Carvedilol markedly reduced HVPG, from 19.5 ± 1.3 to 15.4 ± 1 mm Hg (P < .0001). This HVPG reduction was greater than after propranolol (−20.4 ± 2 vs. −12.7 ± 2%, P < .05). Moreover, carvedilol decreased HVPG greater than 20% of baseline values or to ≤12 mm Hg in a greater proportion of patients (64% vs. 14%, P < .05). Both drugs caused similar reductions in hepatic and azygos blood flows, suggesting that the greater HVPG decrease by carvedilol was because of reduced hepatic and portocollateral resistance. Propranolol caused greater reductions in heart rate and cardiac output than carvedilol, whereas carvedilol caused a greater decrease in mean arterial pressure (−23.1 vs. −11%, P < .05). Thus, carvedilol has a greater portal hypotensive effect than propranolol in patients with cirrhosis, suggesting a greater therapeutic potential. However, it causes arterial hypotension, which calls for careful evaluation before its long-term use
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Abraldes, J. G., Tarantino, I., Turnes, J., Garcia-Pagan, J. C., Rodés, J., & Bosch, J. (2003) · Hepatology · doi:10.1053/jhep.2003.50133 · Cited by 529
Self-citationComplications of cirrhosis. I. Portal hypertension
Bosch, J., & García-Pagán, J. C. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80422-5 · Cited by 490
Self-citationGarcia–Tsao, G. (2001) · Gastroenterology · doi:10.1053/gast.2001.22580 · Cited by 471
Reiberger, T., Ulbrich, G., Ferlitsch, A., Payer, B. A., Schwabl, P., Pinter, M., Heinisch, B. B., Trauner, M., Kramer, L., Peck-Radosavljevic, M., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-304038 · Cited by 342
Tripathi, D., Ferguson, J. W., Kochar, N., Leithead, J. A., Therapondos, G., Mcavoy, N. C., Stanley, A. J., Forrest, E. H., Hislop, W. S., Mills, P. R., et al. (2009) · Hepatology · doi:10.1002/hep.23045 · Cited by 305
Metadata
- Authors
- Bañares, R., Moitinho, E., Piqueras, B., Casado, M., García-Pagán, J.-C., de Diego, A., & Bosch, J.
- Venue
- Hepatology
- Published
- 1999-07
- Volume
- 30
- Issue
- 1
- Pages
- 79-83
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2089482666
- Cited by
- 191
- References
- 0
- FWCI
- 3.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Carvedilol, a new nonselective beta-blocker with intrinsic anti-alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis. https://app.cochat.ai/papers/10.1002/hep.510300124
- The paper
- Bañares, R., Moitinho, E., Piqueras, B., Casado, M., García-Pagán, J.-C., de Diego, A., & Bosch, J. (1999). Carvedilol, a new nonselective beta-blocker with intrinsic anti-alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis. Hepatology. https://doi.org/10.1002/hep.510300124
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.